Loading stock data...

Dr. Lal PathLabs Limited

NSE: LALPATHLAB BSE: LALPATHLAB

NSE
2,846.20 -10.80 (-0.38%)

Prev Close

2857

Open Price

2880

Volume

76,488

Today Low / High

2835.1 / 2885

52 WK Low / High

2293.55 / 3653.95

Range

2,704 - 2,989

BSE
2,849.35 -7.45 (-0.26%)

Prev Close

2856.8

Open Price

2985.35

Volume

1,322

Today Low / High

2841.05 / 2985.35

52 WK Low / High

2295.1 / 3645

Range

2,707 - 2,992

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 2846.2 (target range: 2,704 - 2,989), reflecting a change of -10.8 (-0.37802%). On the BSE, it is listed at 2849.35 (target range: 2,707 - 2,992), showing a change of -7.45 (-0.26078%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

06 Jun 2,880.00 -1.17%
05 Jun 2,865.00 -0.28%
04 Jun 2,848.00 0.08%
03 Jun 2,765.00 2.13%
02 Jun 2,800.00 -1.21%
30 May 2,852.00 -2.29%
29 May 2,847.00 -0.62%
28 May 2,848.80 -0.77%
27 May 2,874.90 -0.91%
26 May 2,850.00 0.49%
23 May 2,829.80 0.71%
22 May 2,835.00 -0.52%
21 May 2,835.00 0.01%
20 May 2,823.60 -0.08%
19 May 2,820.00 -0.91%
16 May 2,814.00 -0.51%
15 May 2,810.60 -0.64%
14 May 2,809.80 -0.12%
13 May 2,812.00 -1.15%
12 May 2,830.60 -0.83%
09 May 2,739.00 1.29%

Dr. Lal PathLabs Limited Graph

Dr. Lal PathLabs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dr. Lal PathLabs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2,846.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 2,849.35 2,877.84 2,590.06 - 3,165.63
2,906.34 2,325.07 - 3,487.60
2,934.83 2,054.38 - 3,815.28
Bearish Scenario 2,849.35 2,820.86 2,538.77 - 3,102.94
2,792.36 2,233.89 - 3,350.84
2,763.87 1,934.71 - 3,593.03

Overview of Dr. Lal PathLabs Limited

ISIN

INE600L01024

Industry

Medical - Diagnostics & Research

Vol.Avg

190,682

Market Cap

237,279,832,796

Last Dividend

24

Official Website

Visit Website

IPO Date

2015-12-23

DCF Diff

-4,285.00

DCF

7,131

Financial Ratios Every Investor Needs

Stock Dividend of LALPATHLAB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-06-06 June 06, 25 6 6 2025-06-06 2025-07-27
2025-02-05 February 05, 25 6 6 2025-02-05 2025-03-01
2024-11-05 November 05, 24 6 6 2024-11-05 2024-11-22
2024-08-20 August 20, 24 6 6 2024-08-20 2024-09-06
2024-06-10 June 10, 24 6 6 2024-06-10 2024-07-29

Stock Rating Details for LALPATHLAB

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 2,226.64 Cr 947.61 Cr 1,279.03 Cr 0.5744 0.00 Cr 122.27 Cr 865.50 Cr 357.74 Cr 43.05 678.15 Cr 0.1607
2023-03-31 2,016.90 Cr 447.20 Cr 1,569.70 Cr 0.7783 3.60 Cr 282.03 Cr 340.15 Cr 238.85 Cr 28.82 531.55 Cr 0.1184
2022-03-31 2,087.28 Cr 786.79 Cr 1,300.49 Cr 0.6231 3.39 Cr 131.02 Cr 454.71 Cr 344.80 Cr 41.70 613.26 Cr 0.1652
2021-03-31 1,581.27 Cr 397.26 Cr 1,184.01 Cr 0.7488 0.00 Cr 87.17 Cr 359.78 Cr 291.62 Cr 35.33 487.58 Cr 0.1844
2020-03-31 1,330.36 Cr 298.70 Cr 1,031.65 Cr 0.7755 0.00 Cr 86.23 Cr 270.91 Cr 225.94 Cr 27.42 398.61 Cr 0.1698

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 360.93 Cr 2,455.96 Cr 570.60 Cr 1,849.2830 Cr 246.93 Cr -114.00 Cr 37.31 Cr 346.98 Cr 22.48 Cr 0.00 Cr 65.40 Cr 465.1880 Cr
2023-03-31 263.70 Cr 2,385.50 Cr 686.00 Cr 1,666.3000 Cr 419.50 Cr 155.80 Cr 33.80 Cr 404.00 Cr 75.90 Cr 83.33 Cr -547.20 Cr 469.8000 Cr
2022-03-31 378.20 Cr 2,353.22 Cr 809.68 Cr 1,508.0770 Cr 532.44 Cr 154.24 Cr 52.54 Cr 444.85 Cr 91.10 Cr 166.93 Cr -315.30 Cr 499.9880 Cr
2021-03-31 244.30 Cr 1,661.33 Cr 385.32 Cr 1,245.0590 Cr 150.37 Cr -93.93 Cr 42.56 Cr 317.62 Cr 66.25 Cr 0.24 Cr -735.75 Cr 274.2850 Cr
2020-03-31 196.72 Cr 1,374.31 Cr 320.28 Cr 1,032.8080 Cr 129.37 Cr -67.35 Cr 56.96 Cr 302.10 Cr 67.05 Cr 0.00 Cr -521.11 Cr 227.3070 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 535.3340 Cr -24.2690 Cr -413.8630 Cr 477.9000 Cr 97.2020 Cr 360.9330 Cr -51.1670 Cr 357.7350 Cr -153.3370 Cr -201.1690 Cr -3.5000 Cr
2023-03-31 456.0000 Cr -287.3000 Cr -283.2000 Cr 411.4000 Cr -114.5000 Cr 263.7000 Cr -44.6000 Cr 241.1000 Cr -143.1760 Cr -103.0130 Cr 18.7000 Cr
2022-03-31 446.6940 Cr -449.2470 Cr 136.4510 Cr -29.4490 Cr 133.8970 Cr 378.1950 Cr -476.1430 Cr 350.2910 Cr 345.4000 Cr -116.6600 Cr -9.9830 Cr
2021-03-31 398.1500 Cr -212.0160 Cr -138.5560 Cr 338.5600 Cr 47.5780 Cr 244.2980 Cr -59.5900 Cr 296.4790 Cr -23.5270 Cr -99.4830 Cr 14.4020 Cr
2020-03-31 283.8900 Cr -26.1140 Cr -190.4450 Cr 204.2730 Cr 67.3310 Cr 196.7180 Cr -79.6170 Cr 227.5870 Cr 0.0000 Cr -155.5020 Cr -28.4250 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 596.70 Cr 203.70 Cr 393.00 Cr 0.6586 118.50 Cr 96.70 Cr 11.60 179.10 Cr 0.1621
2024-09-30 660.20 Cr 380.30 Cr 279.90 Cr 0.4240 167.20 Cr 129.20 Cr 15.52 224.40 Cr 0.1957
2024-06-30 601.90 Cr 354.40 Cr 247.50 Cr 0.4112 135.30 Cr 106.40 Cr 12.78 190.60 Cr 0.1768
2024-03-31 545.40 Cr 326.50 Cr 218.90 Cr 0.4014 108.10 Cr 84.54 Cr 10.13 163.10 Cr 0.1550
2023-12-31 538.90 Cr 184.70 Cr 354.20 Cr 0.6573 122.90 Cr 81.30 Cr 9.77 158.90 Cr 0.1509

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 106.80 Cr 1,053.90 Cr 1,160.70 Cr 0.00 Cr 46.80 Cr 1,325.60 Cr 329.10 Cr 2,597.50 Cr 562.30 Cr
2024-06-30 -942.60 Cr 1,885.19 Cr 942.60 Cr 0.00 Cr 0.00 Cr 942.60 Cr 0.00 Cr 0.00 Cr -1,885.36 Cr
2024-03-31 830.30 Cr 113.80 Cr 944.10 Cr 77.40 Cr 37.30 Cr 1,126.70 Cr 347.00 Cr 2,456.00 Cr 570.60 Cr
2023-12-31 -896.80 Cr 1,793.60 Cr 896.80 Cr 0.00 Cr 0.00 Cr 896.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 120.00 Cr 809.50 Cr 929.50 Cr 85.50 Cr 40.90 Cr 1,078.80 Cr 356.80 Cr 2,445.30 Cr 639.20 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 106.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 84.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 81.30 Cr 72.00 Cr 0.00 Cr 0.00 Cr 72.00 Cr 858.40 Cr 786.40 Cr 0.00 Cr 72.00 Cr
2023-09-30 109.30 Cr 71.80 Cr 0.00 Cr 0.00 Cr 71.80 Cr 786.40 Cr 714.60 Cr 0.00 Cr 71.80 Cr
2023-06-30 82.60 Cr 70.20 Cr 0.00 Cr 0.00 Cr 70.20 Cr 334.98 Cr 264.78 Cr 0.00 Cr 70.20 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹2,846.20 ₹237,279,832,796.00 ₹76,488.00
Vijaya Diagnostic Centre Limited VIJAYA ₹975.00 ₹100,070,373,000.00 ₹277,592.00
Metropolis Healthcare Limited METROPOLIS ₹1,652.20 ₹85,583,960,000.00 ₹78,720.00
Thyrocare Technologies Limited THYROCARE ₹952.80 ₹50,492,206,800.00 ₹203,448.00

Key Executives

Chief Executive Officer
Mr. Shankha Banerjee

Gender: male

Year Born:

Chief Operating Officer
Mr. Jai Prakash Meena

Gender: male

Year Born:

Group Chief Financial Officer & Chief Executive Officer of International Business
Mr. Ved Prakash Goel C.A.

Gender: male

Year Born:

Group Chief Human Resources Officer
Mr. Manoj Kumar Garg

Gender: male

Year Born: 1969

Executive Director
Dr. Vandana Lal

Gender: Not Specified

Year Born: 1956

Company Secretary & Compliance Officer
Mr. Vinay Gujral

Gender: male

Year Born:

Executive Chairman
Brigadier Arvind Lal

Gender: Not Specified

Year Born: 1949

Chief Information & Digital Officer
Mr. Munender Soperna

Gender: male

Year Born:

FAQs about Dr. Lal PathLabs Limited

Who is the CEO of the company?

The CEO is Mr. Shankha Banerjee.

What is the current market price of the stock?

The current price is ₹2,846.20.

What is the 52-week price range?

The range is ₹2293.55-3653.95.

What is the market capitalization of the company?

The market capitalization is ₹23,727.98 crores.

What is the dividend yield?

The dividend yield is 1.05%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 56.92.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dr. Lal PathLabs Limited (ISIN: INE600L01024) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹23,727.98 crores and an average daily volume of 190,682 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹24.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack